Related references
Note: Only part of the references are listed.Secretory clusterin promotes oral cancer cell survival via inhibiting apoptosis by activation of autophagy in AMPK/mTOR/ULK1 dependent pathway
Prajna Paramita Naik et al.
LIFE SCIENCES (2021)
Crosstalk between autophagy and metabolic regulation of cancer stem cells
Mouradi El Hout et al.
MOLECULAR CANCER (2020)
ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity
Sonia Alcala et al.
NATURE COMMUNICATIONS (2020)
BNIP3L-Dependent Mitophagy Promotes HBx-Induced Cancer Stemness of Hepatocellular Carcinoma Cells via Glycolysis Metabolism Reprogramming
Yuan-Yuan Chen et al.
CANCERS (2020)
Mitophagy-driven metabolic switch reprograms stem cell fate
Prajna Paramita Naik et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins
Elizaveta E. Alemasova et al.
NUCLEIC ACIDS RESEARCH (2019)
Folate can promote the methionine-dependent reprogramming of glioblastoma cells towards pluripotency
Racha Zgheib et al.
CELL DEATH & DISEASE (2019)
Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC
Gro V. Rosland et al.
CANCER & METABOLISM (2019)
Aldolase A overexpression is associated with poor prognosis and promotes tumor progression by the epithelial-mesenchymal transition in colon cancer
Feng Ye et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance
Tianyi Wang et al.
CELL METABOLISM (2018)
Metabolic traits of cancer stem cells
Joana Peixoto et al.
DISEASE MODELS & MECHANISMS (2018)
Emerging role of lipid metabolism alterations in Cancer stem cells
Mei Yi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Low-folate stress reprograms cancer stem cell-like potentials and bioenergetics metabolism through activation of mTOR signaling pathway to promote in vitro invasion and in vivo tumorigenicity of lung cancers
Wan-Jing Chen et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2018)
Cancer Stem Cell Metabolism and Potential Therapeutic Targets
Vusala Snyder et al.
FRONTIERS IN ONCOLOGY (2018)
Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity
Gloria Bonuccelli et al.
ONCOTARGET (2017)
Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression
Terumasa Sowa et al.
CANCER MEDICINE (2017)
188Re-Liposome Can Induce Mitochondrial Autophagy and Reverse Drug Resistance for Ovarian Cancer: From Bench Evidence to Preliminary Clinical Proof-of-Concept
Chia-Ming Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells
Hengqiang Zhao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma
Qiuran Xu et al.
MOLECULAR CANCER (2017)
Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation
Su Yeon Lee et al.
MOLECULAR CANCER (2017)
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation (vol 480, pg 118, 2011)
Weiwei Yang et al.
NATURE (2017)
Cancer metabolism: a therapeutic perspective (vol 14, pg 11, 2017)
Ubaldo E. Martinez-Outschoorn et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress
Nam Hee Kim et al.
NATURE COMMUNICATIONS (2017)
Metabolomic mapping of cancer stem cells for reducing and exploiting tumor heterogeneity
Elisabet Cuyas et al.
ONCOTARGET (2017)
Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer
Davinder Singh et al.
CELL AND BIOSCIENCE (2017)
Aldolase B Overexpression is Associated with Poor Prognosis and Promotes Tumor Progression by Epithelial-Mesenchymal Transition in Colorectal Adenocarcinoma
Qingguo Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation
Kyung-Min Lee et al.
CELL METABOLISM (2017)
Fatty acid synthesis is critical for stem cell pluripotency via promoting mitochondrial fission
Lihua Wang et al.
EMBO JOURNAL (2017)
Mitophagy-driven mitochondrial rejuvenation regulates stem cell fate
Alejandro Vazquez-Martin et al.
AGING-US (2016)
LDH-A promotes malignant progression via activation of epithelial-to-mesenchymal transition and conferring stemness in muscle-invasive bladder cancer
Fujin Jiang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Hallmarks of cancer stem cell metabolism
Patricia Sancho et al.
BRITISH JOURNAL OF CANCER (2016)
NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism
Chia-Lin Chen et al.
CELL METABOLISM (2016)
HSP90 inhibits apoptosis and promotes growth by regulating HIF-1α abundance in hepatocellular carcinoma
Xin Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors
Gao Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Implications of cancer stem cells in developing therapeutic resistance in oral cancer
Prajna Paramita Naik et al.
ORAL ONCOLOGY (2016)
Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program
Esther Aguilar et al.
STEM CELLS (2016)
A FASN-TGF-β1-FASN regulatory loop contributes to high EMT/metastatic potential of cisplatin-resistant non-small cell lung cancer
Li Yang et al.
ONCOTARGET (2016)
Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch
Su Yeon Lee et al.
ONCOTARGET (2016)
Suppression of endogenous lipogenesis induces reversion of the malignant phenotype and normalized differentiation in breast cancer
Anatilde M. Gonzalez-Guerrico et al.
ONCOTARGET (2016)
Spheroid cancer stem cells display reprogrammed metabolism and obtain energy by actively running the tricarboxylic acid (TCA) cycle
Masakazu Sato et al.
ONCOTARGET (2016)
Metaboloepigenetics: The Emerging Network in Stem Cell Homeostasis Regulation
Daniele Avitabile et al.
CURRENT STEM CELL RESEARCH & THERAPY (2016)
Oncometabolic Nuclear Reprogramming of Cancer Stemness
Javier A. Menendez et al.
STEM CELL REPORTS (2016)
Cancer Stem Cells in Small Cell Lung Cancer Cell Line H446: Higher Dependency on Oxidative Phosphorylation and Mitochondrial Substrate-Level Phosphorylation than Non-Stem Cancer Cells
Cuicui Gao et al.
PLOS ONE (2016)
Nuclear reprogramming of cancer stem cells: Corrupting the epigenetic code of cell identity with oncometabolites
Javier A. Menendez et al.
MOLECULAR & CELLULAR ONCOLOGY (2016)
A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission
Jing Zhou et al.
AUTOPHAGY (2015)
Epithelial-mesenchymal transition induces similar metabolic alterations in two independent breast cancer cell lines
Yuvabharath Kondaveeti et al.
CANCER LETTERS (2015)
The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism
Jianrong Lu et al.
CANCER LETTERS (2015)
Metabolic control of cancer cell stemness: Lessons from iPS cells
Javier A. Menendez
CELL CYCLE (2015)
Mitofusins deficiency elicits mitochondrial metabolic reprogramming to pluripotency
M. J. Son et al.
CELL DEATH AND DIFFERENTIATION (2015)
MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells
Patricia Sancho et al.
CELL METABOLISM (2015)
The Metaboloepigenetic Dimension of Cancer Stem Cells: Evaluating the Market Potential for New Metabostemness-Targeting Oncology Drugs
Javier A. Menendez
CURRENT PHARMACEUTICAL DESIGN (2015)
Oncometabolites: tailoring our genes
Stefan Nowicki et al.
FEBS JOURNAL (2015)
Dlx-2 is implicated in TGF-β- and Wnt-induced epithelial-mesenchymal, glycolytic switch, and mitochondrial repression by Snail activation
Su Yeon Lee et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant
Gillian Farnie et al.
ONCOTARGET (2015)
Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma
Yao-An Shen et al.
CELL CYCLE (2015)
WNT Signaling: an Emerging Mediator of Cancer Cell Metabolism?
Victoria Sherwood
MOLECULAR AND CELLULAR BIOLOGY (2015)
Pro-Oxidant Activity of Amine-Pyridine-Based Iron Complexes Efficiently Kills Cancer and Cancer Stem-Like Cells
Marta Gonzalez-Bartulos et al.
PLOS ONE (2015)
Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells
Weibo Luo et al.
Oncotarget (2015)
Metabolic differences in breast cancer stem cells and differentiated progeny
Erina Vlashi et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Gerometabolites The pseudohypoxic aging side of cancer oncometabolites
Javier A. Menendez et al.
CELL CYCLE (2014)
IDH mutations in liver cell plasticity and biliary cancer
Supriya K. Saha et al.
CELL CYCLE (2014)
Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway
P-P Liu et al.
CELL DEATH AND DIFFERENTIATION (2014)
Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma
Darrell R. Borger et al.
CLINICAL CANCER RESEARCH (2014)
Wnt meets Warburg: another piece in the puzzle?
Craig B. Thompson
EMBO JOURNAL (2014)
Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer
Kira T. Pate et al.
EMBO JOURNAL (2014)
Energy Metabolism Characterization of a Novel Cancer Stem Cell-Like Line 3AB-OS
Roberta Palorini et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Andrea Viale et al.
NATURE (2014)
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer
Supriya K. Saha et al.
NATURE (2014)
PGC-lα mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis
Valerie S. LeBleu et al.
NATURE CELL BIOLOGY (2014)
Rare insights into cancer biology
J. Adam et al.
ONCOGENE (2014)
Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism
Jianqun Liao et al.
PLOS ONE (2014)
Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition
Atsushi Hamabe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment
D. Ciavardelli et al.
CELL DEATH & DISEASE (2014)
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect
Paula Lopez-Serra et al.
NATURE COMMUNICATIONS (2014)
Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition
Rebecca Lamb et al.
ONCOTARGET (2014)
Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation
Anna Pasto et al.
ONCOTARGET (2014)
Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells
Bruna Corominas-Faja et al.
ONCOTARGET (2014)
A Systems Approach to Predict Oncometabolites via Context-Specific Genome-Scale Metabolic Networks
Hojung Nam et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
Metabostemness: a new cancer hallmark
Javier A. Menendez et al.
FRONTIERS IN ONCOLOGY (2014)
Cancer: pathological nuclear reprogramming?
Colin R. Goding et al.
NATURE REVIEWS CANCER (2014)
Defects in mitochondrial metabolism and cancer
Edoardo Gaude et al.
CANCER & METABOLISM (2014)
PGC1α Expression Defines a Subset of Human Melanoma Tumors with Increased Mitochondrial Capacity and Resistance to Oxidative Stress
Francisca Vazquez et al.
CANCER CELL (2013)
Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer
Chenfang Dong et al.
CANCER CELL (2013)
The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells
Javier A. Menendez et al.
CELL CYCLE (2013)
Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway
Bruna Corominas-Faja et al.
CELL CYCLE (2013)
Metabolic Regulation by p53 Family Members
Celia R. Berkers et al.
CELL METABOLISM (2013)
BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells
Eleni D. Lagadinou et al.
CELL STEM CELL (2013)
IDH mutations in tumorigenesis and their potential role as novel therapeutic targets
Daniel Krell et al.
FUTURE ONCOLOGY (2013)
Oncometabolites: linking altered metabolism with cancer
Ming Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The secretome of colon cancer stem cells contains drug-metabolizing enzymes
Benjamin L. Emmink et al.
JOURNAL OF PROTEOMICS (2013)
The Proto-oncometabolite Fumarate Binds Glutathione to Amplify ROS-Dependent Signaling
Lucas B. Sullivan et al.
MOLECULAR CELL (2013)
Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer
P. R. Pandey et al.
ONCOGENE (2013)
Oncogenic Isocitrate Dehydrogenase Mutations: Mechanisms, Models, and Clinical Opportunities
Rob A. Cairns et al.
CANCER DISCOVERY (2013)
Mitochondrial fusion by pharmacological manipulation impedes somatic cell reprogramming to pluripotency: New insight into the role of mitophagy in cell stemness
Alejandro Vazquez-Martin et al.
AGING-US (2012)
The molecular and mathematical basis of Waddington's epigenetic landscape: A framework for post-Darwinian biology?
Sui Huang
BIOESSAYS (2012)
Wnt/Snail Signaling Regulates Cytochrome c Oxidase and Glucose Metabolism
Su Yeon Lee et al.
CANCER RESEARCH (2012)
Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells
Mayumi Tamada et al.
CANCER RESEARCH (2012)
STAT3 can serve as a hit in the process of malignant transformation of primary cells
M. Demaria et al.
CELL DEATH AND DIFFERENTIATION (2012)
Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy
Tineke W. H. Meijer et al.
CLINICAL CANCER RESEARCH (2012)
PKM2: a new player in the β-catenin game
Frederic Canal et al.
FUTURE ONCOLOGY (2012)
Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells
Michalina Janiszewska et al.
GENES & DEVELOPMENT (2012)
Nicotinamide-induced Mitophagy EVENT MEDIATED BY HIGH NAD+/NADH RATIO AND SIRT1 PROTEIN ACTIVATION
So-young Jang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Regulation of reactive oxygen species in stem cells and cancer stem cells
Chiharu I. Kobayashi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Metaboloepigenetics: Interrelationships between energy metabolism and epigenetic control of gene expression
Dallas R. Donohoe et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival
V. Goidts et al.
ONCOGENE (2012)
The emerging role of fumarate as an oncometabolite
Ming Yang et al.
FRONTIERS IN ONCOLOGY (2012)
p53 and metabolism Old player in a new game
Nirmalya Sen et al.
TRANSCRIPTION-AUSTIN (2012)
Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
Wei Xu et al.
CANCER CELL (2011)
Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial-Mesenchymal Transition Regulated by miR-200 in Breast Cancer Cells
Aamir Ahmad et al.
CANCER RESEARCH (2011)
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Weibo Luo et al.
CELL (2011)
Somatic Oxidative Bioenergetics Transitions into Pluripotency-Dependent Glycolysis to Facilitate Nuclear Reprogramming
Clifford D. L. Folmes et al.
CELL METABOLISM (2011)
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Rasheduzzaman Chowdhury et al.
EMBO REPORTS (2011)
Mammalian Sirtuins and Energy Metabolism
Xiaoling Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Metabolic Alterations in Highly Tumorigenic Glioblastoma Cells PREFERENCE FOR HYPOXIA AND HIGH DEPENDENCY ON GLYCOLYSIS
Yunfei Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Inborn and acquired metabolic defects in cancer
Christian Frezza et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Metabolic regulation by p53
Oliver D. K. Maddocks et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
PGC-1α, a Key Modulator of p53, Promotes Cell Survival upon Metabolic Stress
Nirmalya Sen et al.
MOLECULAR CELL (2011)
Mechanisms of mitophagy
Richard J. Youle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme
Amparo Wolf et al.
NEUROBIOLOGY OF DISEASE (2011)
Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer
Mingquan Chen et al.
PLOS ONE (2011)
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward et al.
CANCER CELL (2010)
Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved Issues
Jacob H. Hanna et al.
CELL (2010)
Histone Methyl Transferases and Demethylases; Can They Link Metabolism and Transcription?
Raffaele Teperino et al.
CELL METABOLISM (2010)
p53 connects tumorigenesis and reprogramming to pluripotency
Natalia Tapia et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells
Rachel Sarig et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Energetics, epigenetics, mitochondrial genetics
Douglas C. Wallace et al.
MITOCHONDRION (2010)
Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis
X. Liu et al.
ONCOGENE (2010)
Regulation of Cellular Metabolism by Protein Lysine Acetylation
Shimin Zhao et al.
SCIENCE (2010)
Reprogramming cell fates: reconciling rarity with robustness
Sui Huang
BIOESSAYS (2009)
Metabolic defects provide a spark for the epigenetic switch in cancer
Michael J. Hitchler et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
The role of poly(ADP-ribosyl)ation in epigenetic events
Delphine Quenet et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Linking the p53 tumour suppressor pathway to somatic cell reprogramming
Teruhisa Kawamura et al.
NATURE (2009)
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Ping Gao et al.
NATURE (2009)
A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
Rosa M. Marion et al.
NATURE (2009)
Suppression of induced pluripotent stem cell generation by the p53-p21 pathway
Hyenjong Hong et al.
NATURE (2009)
Immortalization eliminates a roadblock during cellular reprogramming into iPS cells
Jochen Utikal et al.
NATURE (2009)
The Ink4/Arf locus is a barrier for iPS cell reprogramming
Han Li et al.
NATURE (2009)
mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome
David B. Shackelford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
Chunaram Choudhary et al.
SCIENCE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation
Kathryn E. Wellen et al.
SCIENCE (2009)
Cancer attractors: A systems view of tumors from a gene network dynamics and developmental perspective
Sui Huang et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2009)
Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription
Jungwoon Lee et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia
Huafeng Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species
Chong Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
P53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation
Keiko Kawauchi et al.
NATURE CELL BIOLOGY (2008)
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Nicholas C. Denko
NATURE REVIEWS CANCER (2008)
A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche
Yoon-Young Jang et al.
BLOOD (2007)
p53 is regulated by the lysine demethylase LSD1
Jing Huang et al.
NATURE (2007)
NAD+ metabolism in health and disease
Peter Belenky et al.
TRENDS IN BIOCHEMICAL SCIENCES (2007)
Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect
Michelle B. Bowie et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Substrate and functional diversity of lysine acetylation revealed by a proteomics survey
Sung Chan Kim et al.
MOLECULAR CELL (2006)
TIGAR, a p53-inducible regulator of glycolysis and apoptosis
Karim Bensaad et al.
CELL (2006)
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
A Brunet et al.
SCIENCE (2004)
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
F Picard et al.
NATURE (2004)
Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis
YJ Lee et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Expression of peroxisome-proliferator activated receptor-gamma (PPARγ) and the PPAR-γ co-activator, PGC-I, in human breast cancer correlates with clinical outcomes
WG Jiang et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Glucose metabolism in cancer - Evidence that demethylation events play a role in activating type II hexokinase gene expression
A Goel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase
H Vaziri et al.
CELL (2001)
Share Paper
